[7], [23] Optimal management of patients with indolent small intestinal CD4+ T-cell lymphomas is unclear. Therapy with oral or luminal, non-absorbable steroids led to good symptom control in our patients, although none achieved remission, similar to prior reports. [14], [16], [17] Aggressive therapy with a variety of chemotherapy regimens in the past has also been unsuccessful (Table 3). This evidence concerns the gene CD4 and T-cell non-Hodgkin lymphoma.